Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep490 | Pituitary and Neuroendocrinology | ECE2021

Third month MRI predicts macroprolactinoma reduction after cabergoline therapy

Biagetti Betina , Sarria-Estrada Silvana , Ng-Won Karelis , Martinez-Saez Elena , Casteras Anna , Cordero-Asanza Esteban , Irene Hernández-Hernández , Efrain Cordero-Vazquez. , Alba Rojano , Canonge Rafael Simo

BackgroundTranssphenoidal surgery is in general the preferred first-line treatment for patients with macroadenomas except for prolactinomas, which is mainly indicated when the treatment with dopamine agonists (DA) fails. However, in those patients resistant to DA (i.e. volume reduction ObjectiveTo identify predictors of DA resistance in order...